Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that is clinically defined as lacking estrogen and progesterone receptors, as well as being ERBB2 (HER-2) negative. Without specific therapeutic targets, TNBC carries a worse prognosis than other types of breast cancer in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiller, David J., Chu, Quyen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262603/
https://www.ncbi.nlm.nih.gov/pubmed/22295252
http://dx.doi.org/10.1155/2012/829315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262603/
https://www.ncbi.nlm.nih.gov/pubmed/22295252
http://dx.doi.org/10.1155/2012/829315

Ejemplares similares